• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

U.S. Justice Dept.

Baxter cleared from DoJ antitrust saline probe

February 1, 2019 By Fink Densford

Baxter (NYSE:BAX) said yesterday that it has been cleared from a U.S. Dept. of Justice antitrust probe, launched in 2017, investigating companies that market intravenous saline solutions. The probe came as hospitals endured a shortage of intravenous saline solutions, which are used to hydrate hospital patients. The shortage dates back to late 2013, after drugmakers told […]

Filed Under: Featured, Hospital Care, Legal News, Pharmaceuticals Tagged With: Baxter, U.S. Justice Dept.

Hospira, Baxter subpoenaed in antitrust probe over intravenous saline

April 21, 2017 By Sarah Faulkner

gavel

Drugmakers received grand jury subpoenas from the U.S. Justice Dept. this week in connection with an antitrust probe into companies that market intravenous saline solutions. ICU Medical (NSDQ:ICUI), which recently acquired Hospira Infusion Systems from Pfizer (NYSE:PFE), and Baxter (NYSE:BAX) disclosed the subpoenas this week. Pfizer revealed that it is also wrapped up in the investigation, according […]

Filed Under: Featured, Hospital Care, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: B. Braun Medical, Baxter International, ICU Medical, Pfizer Inc., U.S. Justice Dept.

EpiPen purchasers level class action against Mylan over price hikes

April 4, 2017 By Sarah Faulkner

Mylan

Mylan (NSDQ:MYL) was hit with another class action lawsuit over the price of its EpiPen device yesterday. The lawsuit, which was filed in the Washington Western District Court, alleges that Mylan engaged in a scheme with pharmacy benefit managers to dominate the market and overcharge customers. Although the Canonsburg, Penn.-based company has been hit with several lawsuits […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Centers for Medicare and Medicaid Services (CMS), CVS Health, Express Scripts, Mylan, OptumRx, U.S. Justice Dept.

Shire to pay feds $350m to settle Dermagraft kickbacks case

January 12, 2017 By Sarah Faulkner

Shire

The U.S. Justice Dept. said yesterday that Shire (NSDQ:SHPG) and its subsidiaries will cough up $350 million to settle allegations that Shire and the company it acquired in 2011, Advanced BioHealing, gave kickbacks to clinics and physicians in exchange for using its bioengineered human skin substitute, Dermagraft. “This settlement represents the largest False Claims Act recovery by the […]

Filed Under: Diabetes, Featured, Legal News, Wall Street Beat Tagged With: Advanced BioHealing, Shire, U.S. Justice Dept.

Ex pharma execs first to be charged in generic drug pricing case

December 15, 2016 By Sarah Faulkner

Former Heritage Pharmaceuticals CEO Jeffrey Glazer and ex-president Jason Malek were hit yesterday with the 1st criminal charges from a 2-year federal investigation in an ongoing generic drug pricing case. The 2 former executives were charged by federal authorities with price collusion for doxycycline hyclate, a widely used antibiotic, and a diabetes therapy called glyburide […]

Filed Under: Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Heritage Pharmaceuticals, Mylan, Teva Pharmaceuticals, U.S. Justice Dept.

Senate panel adds to call for hearings over Mylan’s EpiPen pricing

November 8, 2016 By Sarah Faulkner

Mylan

The U.S. Senate Judiciary Committee yesterday called on the Federal Trade Commission to investigate whether Mylan (NSDQ:MYL) broke the law after reports claimed the EpiPen maker prevented schools from buying competing allergy treatments. In a letter penned to the FTC, committee chairman Sen. Charles Grassley (R-Iowa) and ranking member Sen. Patrick Leahy (D-Vt.) wrote, “increasing patient access […]

Filed Under: Drug-Device Combinations, Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Federal Trade Commission (FTC), Mylan, U.S. Justice Dept.

UPDATE: BTG’s U.S. Biocompatibles business to pay $36m settlement, plead guilty to misbranding

November 8, 2016 By Brad Perriello

BTG wins CE Mark for DC Bead Lumi radiopaque drug-eluting bead

Updated to include BTG’s guilty plea entered Nov 7. BTG (LON:BTG) said today that it agreed to pay the U.S. Justice Dept. $36 million (£28.4 million) to settle a probe into the marketing of the LC Bead embolization microspheres made by its Biocompatibles subsidiary. The company plead guilty on Monday, November 7, to charges of improperly marketing […]

Filed Under: Drug-Device Combinations, Legal News, Wall Street Beat Tagged With: BTG, U.S. Justice Dept.

Mylan, Teva crash on report that Justice Dept. could file charges in generic pricing probes

November 4, 2016 By Sarah Faulkner

Mylan

The U.S. Justice Dept. could reportedly file charges in its generic-drug pricing probe into companies including Mylan Pharmaceuticals (NSDQ:MYL) and Teva Pharmaceuticals (NYSE:TEVA) by the end of year. The department is examining whether the generic drug makers colluded on drug pricing, Bloomberg reported yesterday. The news source said that Mylan and Teva have disclosed subpoenas and are cooperating […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Legal News Tagged With: Mylan, Teva Pharmaceuticals, U.S. Justice Dept.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS